TD Cowen Maintains Buy on PROCEPT BioRobotics, Lowers Price Target to $34
Benzinga Newsdesk 8 months ago
NewsPrice TargetAnalyst Ratings
TD Cowen analyst Joshua Jennings maintains PROCEPT BioRobotics (NASDAQ:PRCT) with a Buy and lowers the price target from $50 to $34.
TD Cowen analyst Joshua Jennings maintains PROCEPT BioRobotics (NASDAQ:PRCT) with a Buy and lowers the price target from $50 to $34.